Episode

Episode 412: Pharmacology 101: Cytokines

Podcast
The ONS Podcast
Published
Apr 24, 2026
Duration seconds
2118
Processing state
not_requested
Canonical source
https://onsvoice.libsyn.com/episode-412-pharmacology-101-cytokines
Audio
https://traffic.libsyn.com/secure/onsvoice/ONSP_412_final.mp3?dest-id=557038
JSON
/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-412-pharmacology-101-cytokines
Markdown
/podcast/the-ons-podcast-1126448/episode-412-pharmacology-101-cytokines.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-412-pharmacology-101-cytokines/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-ons-podcast-1126448/episode-412-pharmacology-101-cytokines.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

"They are small, powerful little nuggets. They are actually small signaling proteins that our immune cells use to communicate. They really help regulate immune activation or inflammation and even the growth and survival of immune cells. When cytokines are used therapeutically in oncology, they help to stimulate immune cells such as T cells or natural killer cells to better recognize and attack cancer cells," Maribel Pereiras, PharmD, BCPS, BCOP, clinical pharmacy specialist at the John Theurer Cancer Center of Hackensack University Medical Center in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS ® , manager of oncology nursing practice at ONS, during a conversation about the cytokine drug class. Music Credit: " Fireflies and Stardust " by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours (including 30 minutes of pharmacotherapeutic content) of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 24, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Nurses caring for people with cancer require knowledge of cytokines to provide appropriate education and to safely administer related therapies. Episode Notes Complete this evaluation for free NCPD . ONS Podcast ™ episodes: Pharmacology 101 series Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis ONS Voice articles: FDA Approves Nogapendekin Alfa Inbakicept-Pm…